Web Results

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. | Oyez

www.oyez.org/cases/2014/13-854

Oct 15, 2014 ... Sandoz, Inc., et al. ... Teva Pharmaceuticals USA, Inc., the manufacturer of the original drug, sued Sandoz and Mylan and used two different ...

Organon USA Inc. :: Scrip

scrip.pharmamedtechbi.com/companies/_id10871

Government contends a price reduction is the only discount exception to the Anti- Kickback Statute; PhRMA says this interpretation puts companies at risk of ...

May | 2013 | Life Science Matters

druganddeviceblog.com/2013/05/

May 30, 2013 ... Endo Pharmaceuticals, Inc., et al claims the defendants are liable due to the ... May 22, 2013; Thomas O'Grady · Drug/Medical Device ... Merck and Organon USA Inc. asserted that the New Jersey Product Liability Act exclusion of… ... validity and enforceability of Cephalon's RE'516 patent, in Apotex, I...

An Intensive Behavioral Weight Loss Intervention and Hot Flushes in ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3030922/

Dr Grady has received grant support from Berlex Inc, Eli Lilly and Company, and Bionovo Inc for ... paid as a consultant to lead a Data and Safety Monitoring Board for Organon International Inc. ... Rossouw JE, Prentice RL, Manson JE, et al. .... U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA.

Effect of tamoxifen on venous thrombosis risk factors in women ...

onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2003.03976.x/full

Dec 20, 2002 ... In two small studies, tamoxifen slightly lowered (Jones et al, 1992) or did not ... VTE in a factor V Leiden heterozygote (Weitz et al, 1997), but we are unaware ... partial thromboplastin time assay (Organon Teknika, Durham, NC, USA), ...... Copyright © 1999 - 2016 John Wiley & Sons, Inc. All Rights Reserved.

Predictors of proteinuria and renal failure among women with HIV ...

www.sciencedirect.com/science/article/pii/S0085253815481682

Dec 16, 2015 ... 50.4%, P < 0.0001), have a greater HIV RNA level (206,011 vs. 145,509 ..... [SD- 008]. 3; P.L. Kimmel, W.O. Umana, S.J. Simmens, et al. ... 7; T.S. Ahuja, M. Borucki, J. Grady ..... Duke University Medical Center Box 3646, Durham, North Carolina 27710, USA ... Published by Elsevier Inc. All rights reserved.

Risk of Venous Thromboembolic Disease Associated With ...

jamanetwork.com/journals/jamainternalmedicine/fullarticle/217495

Oct 11, 2004 ... Grady DRubin SMPetitti DB et al. .... by factor V Leiden mutation of risk of deep- vein thrombosis associated with oral contraceptives containing ...

The combined contraceptive vaginal ring and bone mineral density ...

humrep.oxfordjournals.org/content/20/10/2764.full.pdf

Apr 22, 2005 ... NV Organon, 5340 BH Oss, The Netherlands ... et al., 2003) or even a negative effect on BMD (Prior et al.,. 2001). .... pendent company (SYNARC, San Francisco , CA, USA) who also ..... Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V,. Vittinghoff E and Grady D (2004) Effects of ultralow-dose ...

Genetic Polymorphisms Influence the Ovarian Response to rFSH ...

journals.plos.org/plosone/article?id=10.1371/journal.pone.0038700

Jun 11, 2012 ... 6.6±3.1 UI/l (p=0.0126) for FSH and 4.8±2.3 IU/l vs. ..... Our results agree with previous data in this respect (Hanevik et al. .... with recombinant FSH (GonalF® from Merck Serono or Puregon® from Organon-Schering ... GENMOD procedure (SAS Institute Inc., Cary, NC, USA), with the hypothesis of a Poisson ...

Endometrial Effects of Tibolone - Endocrine Society Journals and ...

press.endocrine.org/doi/pdf/10.1210/jc.2006-2207

Dec 27, 2006 ... H3T IE2; NV Organon (W.d.H.), 5340 BH Oss, The Netherlands; and Organon International (V.S., F.A.H.), Roseland, New. Jersey 07068 ..... Archer et al. ..... Lev Sverdlov (Biometrics Department, Organon USA, Inc.) for the sta- .... Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D 1995 Hormone.

More Info

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. : SCOTUSblog

www.scotusblog.com

Nov 12 2013, Response to application from respondent Sandoz, Inc., et al. filed. Nov 13 2013, Reply of applicant Teva Pharmaceuticals USA, Inc., et al. filed.

Factors that distinguish college students with depressive symptoms ...

www.ncbi.nlm.nih.gov

Quality of life was significantly lower for those with moderate to severe SI vs those with ... Similar to Farabaugh et al, we found that hopelessness and depressive severity .... Nutrition 21, Orexigen Therapeutics, Inc., Organon Pharmaceuticals, Otsuka ... Medicine Boston University Student Health Services Boston, MA, USA.

Reduced Incidence of Invasive Breast Cancer With Raloxifene - NCBI

www.ncbi.nlm.nih.gov

Jun 10, 2008 ... JS, and JM are employees of Eli Lilly and Company, the maker of raloxifene ( Evista), and hold Eli Lilly stock. ... and Organon, and grant support from Eli Lilly, Organon, and Merck. ... Chlebowski RT, Blackburn GL, Thomson CA, et al. ... et al . Effects of tamoxifen vs raloxifene on the risk of developing invasive ....